Price
No data yet.
Social Signal Score
Revenue
$1.92BAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Wing Fung Siu
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 87
- Beta
- -0.04
- Country
- TH
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -628.88
Financials
Revenue
$1.92B+126582.3%Net Income
$-8.04BEBITDA
$-7.54BFree Cash Flow
—EPS (diluted)
$-491756.79Shares Outstanding (diluted)
16.3K+124.4%Operating Expenses
$4.01BCash & Debt
$1.02MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.73M | $9.88M | $604.80 |
| 2024 | $5.43M | $-525.0K | $-32.13 |
| 2023 | $5.14M | $130.2K | $17.88 |
| 2022 | $5.94M | $458.7K | $62.98 |
| 2021 | $4.12M | $-533.00 | $-0.07 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $888.38
- Implied price
- $3,554
- Return from $0.03
- 957.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $1,767 — today's price is already 100.0% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 0 | 2 | 4 | 6 | 8 |
|---|---|---|---|---|---|
| -2.0% | — | 735.2% | 859.4% | 940.4% | 1002.0% |
| 3.0% | — | 777.8% | 908.3% | 993.5% | 1058.2% |
| 8.0% | — | 820.4% | 957.3% | 1046.6% | 1114.5% |
| 13.0% | — | 863.0% | 1006.2% | 1099.6% | 1170.7% |
| 18.0% | — | 905.6% | 1055.2% | 1152.7% | 1226.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
80-33.33%Social Signal Score
Mentions (6)
- Newsglobenewswire.com·2d ago·Negative
NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering BANGKOK, Nov. 20, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a technology-driven, diversified growth company, today announced the closing of its previously announced firm commitment underwritten offering with gross proceeds to the Company of approximately $2.5 million, before deducting underwriting fees and other offering expenses payable by the Company.
View source ↗ - Newsglobenewswire.com·3d ago·Neutral
NewGenIvf Group Limited Announces Pricing of $2.5 Million Underwritten Offering BANGKOK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a technology-driven, diversified growth company, today announced the pricing of a firm commitment underwritten offering with gross proceeds to the Company expected to be approximately $2.5 million, before deducting underwriting fees and other offering expenses payable by the Company.
View source ↗ - Newsglobenewswire.com·6d ago·Negative
NewGen Provides Business Update BANGKOK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its businesses. Nodexus and NX One In July 2025, the Company acquired advanced cytometry intellectual property and equipment.
View source ↗ - Newsglobenewswire.com·53d ago·Neutral
NewGen Announces Closing of $1.25 Million Public Offering BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross procee…
View source ↗ - Newsglobenewswire.com·55d ago·Positive
NewGen Announces Pricing of $1.25 Million Public Offering BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expe…
View source ↗ - Newsglobenewswire.com·97d ago·Neutral
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange close…
View source ↗
Earnings
Wed, Mar 3(in 3 months)
Consensus estimate $783.36 per share
Typical surprise -49.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Sep 2$581.76 vs $581.76beat
- Wed, Apr 1$146.88 vs $13348.80miss
Estimates and results for NIVF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NIVF officers and directors.
- Bought
- $4.4m
- Sold
- $119k
8 trades
2 trades
- Cheung Kong Yiubought
- Cheung Kong Yiubought
- Hrt Financial Lpsold
- Hrt Financial Lpbought
- Cheung Kong Yiubought
- Hrt Financial Lpbought
- Cheung Kong Yiubought
- Hrt Financial Lpsold
26 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NIVF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
